Accessory Pancreatic Tissue
Accessory pancreatic tissue—also called ectopic or heterotopic pancreas—is a congenital condition in which normal pancreatic tissue is found outside the usual location of the pancreas. The most common sites are the stomach, duodenum, and small intestine, with occasional involvement of other parts of the gastrointestinal tract. Most cases are asymptomatic and discovered incidentally during imaging, endoscopy, or surgery for unrelated reasons. Less commonly, accessory pancreatic tissue can cause symptoms or develop the same diseases as the normally located pancreas, including inflammation or, rarely, tumors. Imaging, endoscopy, and pathology are central to diagnosis.
What is it?
Accessory pancreatic tissue is a congenital condition in which normal-appearing pancreatic tissue develops in a location outside the usual position of the pancreas. The condition is also known as ectopic pancreas or heterotopic pancreas. The abnormal tissue is histologically similar to the rest of the pancreas and may contain the same types of cells, including acinar cells (which produce digestive enzymes), ducts, and, less commonly, islet cells (which produce hormones such as insulin and glucagon). However, the tissue lacks a normal anatomic connection to the main pancreatic ductal system, and any enzymes or hormones it produces are released locally.
Accessory pancreatic tissue is thought to result from small fragments of pancreatic tissue becoming separated from the rest of the developing pancreas during early fetal life. The most common locations are within the gastrointestinal tract, particularly the stomach (especially the antrum near the pylorus), the duodenum, the jejunum, and Meckel diverticulum. Less common locations include the gallbladder, bile ducts, liver, spleen, lymph nodes, mesentery, omentum, and other sites. Accessory pancreatic tissue is relatively common as an incidental finding in autopsy and surgical specimens, with imaging and endoscopy detecting many cases that would otherwise go unrecognized.
Most accessory pancreatic tissue causes no symptoms. The tissue is typically small (most lesions are less than 2 to 3 centimeters), lies just beneath the lining of the affected organ (submucosal), and is identified incidentally during upper endoscopy, imaging, or surgery performed for other reasons. On endoscopy, accessory pancreatic tissue often appears as a smooth, round, submucosal nodule, frequently with a small central dimple or opening that represents the rudimentary duct.
When symptoms do occur, they are usually related to the location, size, or development of complications within the accessory tissue. Larger lesions can cause upper abdominal discomfort, nausea, vomiting, or—when located near the pylorus or in narrow segments of the bowel—obstruction. Bleeding can occur if the surface lining over the tissue ulcerates. Less commonly, accessory pancreatic tissue can develop the same diseases as the normally located pancreas, including inflammation (heterotopic pancreatitis), cysts, abscesses, pseudocysts, and—rarely—tumors. Both benign and malignant tumors of the pancreas have been reported to arise from accessory pancreatic tissue, although these are very uncommon. In children, particularly in unusual locations such as Meckel diverticulum, accessory pancreatic tissue can sometimes be a cause of unexplained gastrointestinal bleeding.
Diagnosis is most often made by endoscopy or imaging. Upper endoscopy frequently identifies a submucosal lesion with a characteristic central dimple in the stomach or duodenum, raising strong suspicion for accessory pancreatic tissue. Endoscopic ultrasound (EUS) provides detailed information about the depth and characteristics of the lesion and can help distinguish it from other submucosal lesions (such as gastrointestinal stromal tumors, lipomas, neuroendocrine tumors, leiomyomas, and others). EUS-guided fine-needle biopsy can sometimes obtain tissue for confirmation, particularly when the diagnosis is uncertain. CT and MRI may identify accessory pancreatic tissue when it is large enough, especially in unusual locations, and can show complications such as inflammation, fluid collections, or surrounding bowel wall changes. Definitive diagnosis is typically made through pathology when the tissue is removed for symptoms, complications, or diagnostic uncertainty.
Important to Know
For the great majority of patients with accessory pancreatic tissue, no specific treatment is needed. Once the diagnosis is confidently established by characteristic endoscopic or imaging findings, most asymptomatic accessory pancreatic tissue can be managed with simple observation. Many small, stable, characteristic lesions do not require any specific follow-up beyond reassurance and clear documentation in the medical record.
Lifestyle changes are generally not needed for typical accessory pancreatic tissue. Patients can usually maintain normal diet, exercise, and activity levels without restriction. There is no need to avoid specific foods or activities solely because of an accessory pancreas, although general healthy habits remain important for overall health.
Treatment is considered in selected situations. These typically include accessory pancreatic tissue that causes significant and persistent symptoms not explained by other conditions (such as recurrent upper abdominal pain, ulceration, or bleeding); complications such as inflammation, abscess formation, obstruction, or significant bleeding; lesions where the diagnosis is uncertain and other conditions—including tumors—cannot be reliably excluded; and lesions in which features raise concern for malignancy. When treatment is needed, endoscopic removal (such as endoscopic mucosal resection or endoscopic submucosal dissection) may be appropriate for selected superficial lesions, while surgical resection is considered for deeper, larger, or otherwise more complex lesions. Treatment decisions are individualized and made in collaboration with gastroenterologists, endoscopists, and surgeons.
When accessory pancreatic tissue is found incidentally during surgery for another reason, the decision about whether to remove it depends on its size, location, accessibility, and the patient’s overall condition. Small, asymptomatic tissue identified incidentally is often left in place, although the surgeon may choose to remove it if it is easily accessible and can be safely excised.
For patients with diagnostic uncertainty—particularly when the imaging or endoscopic appearance overlaps with other submucosal lesions—additional evaluation may be needed. Endoscopic ultrasound with or without biopsy is often the most useful next step, and discussion within a multidisciplinary team can help guide management.
Care is typically coordinated by primary care clinicians and, when relevant, gastroenterologists, endoscopists, general or hepatobiliary surgeons, radiologists, and pathologists. Imaging and laboratory findings are interpreted alongside the patient’s symptoms, examination, and broader clinical context rather than in isolation.
Although accessory pancreatic tissue is almost always a benign and asymptomatic finding, any new abdominal symptoms should be evaluated based on their own clinical features rather than automatically attributed to the previously identified tissue. Coexisting conditions—such as peptic ulcer disease, gallstones, pancreatitis, gastroesophageal reflux, or, rarely, malignancy—can occur and should be considered.
Patients with known accessory pancreatic tissue benefit from clear documentation of the diagnosis in the medical record, which can prevent unnecessary additional testing in the future and ensure that the finding is correctly interpreted on subsequent imaging or endoscopy.
Red flag symptoms include severe persistent upper abdominal pain, persistent vomiting, signs of gastrointestinal bleeding (such as blood in vomit or stool, black or tarry stools), jaundice (yellowing of the skin or eyes), high fever with chills, significant unintentional weight loss, signs of bowel obstruction, severe upper abdominal pain radiating to the back (which may suggest pancreatitis), or sudden change in known abdominal symptoms. These warrant prompt or urgent medical evaluation, as they may indicate complications of the accessory pancreatic tissue or other serious conditions.